Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Tohyama

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|May 18, 2022
Artificial Intelligence in Electrocardiology for Arrhythmia DiagnosisYasushi Mukai, Takeshi Tohyama, Kazuo Sakamoto
Hypertension (Dallas, Tex. : 1979)|December 31, 2019
Smart Baroreceptor Activation Therapy Strikingly Attenuates Blood Pressure Variability in Hypertensive Rats With Impaired BaroreceptorTakeshi Tohyama, Kazuya Hosokawa, Keita Saku, et al.
ESC Heart Failure|February 9, 2022
The use of angiotensin II receptor blocker is associated with greater recovery of cardiac function than angiotensin-converting enzyme inhibitor in dilated cardiomyopathyNobuyuki Enzan, Shouji Matsushima, Tomomi Ide, et al.
JACC. Asia|March 6, 2023
Beneficial Effects of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure With Preserved Ejection Fraction and DiabetesNobuyuki Enzan, Shouji Matsushima, Hidetaka Kaku, et al.
Physiological Reports|October 28, 2025
Simulated microgravity exposure markedly attenuates the baroreflex total loop gain and induces orthostatic hypotension in male ratsKazuhiro Kamada, Hiroshi Mannoji, Takeshi Tohyama, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Beta-blockers are associated with reverse remodeling in patients with dilated cardiomyopathy and mid-range ejection fractionNobuyuki Enzan, Shouji Matsushima, Tomomi Ide, et al.
International Heart Journal|July 19, 2021
The Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Is Associated with the Recovered Ejection Fraction in Patients with Dilated CardiomyopathyNobuyuki Enzan, Shouji Matsushima, Tomomi Ide, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 30, 2023
Regional Variation in the Clinical Practice and Prognosis in Patients With Heart Failure With Reduced Ejection Fraction in Japan - A Report From the Japanese Registry of Acute Decompensated Heart Failure (JROADHF)Yu Sato, Akiomi Yoshihisa, Tomomi Ide, et al.
Open Heart|December 23, 2025
Long-term prognostic impact of in-hospital serum albumin concentration changes in patients hospitalised for heart failureKeiko Fukino, Satoshi Miyata, Tomomi Ide, et al.
Circulation Reports|March 19, 2021
Clinical Characteristics and Contemporary Management of Patients With Cardiomyopathies in Japan - Report From a National Registry of Clinical Personal RecordsNobuyuki Enzan, Shouji Matsushima, Tomomi Ide, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Circulation Journal : Official Journal of the Japanese Circulation Society|May 18, 2022
Artificial Intelligence in Electrocardiology for Arrhythmia DiagnosisYasushi Mukai, Takeshi Tohyama, Kazuo Sakamoto
Hypertension (Dallas, Tex. : 1979)|December 31, 2019
Smart Baroreceptor Activation Therapy Strikingly Attenuates Blood Pressure Variability in Hypertensive Rats With Impaired BaroreceptorTakeshi Tohyama, Kazuya Hosokawa, Keita Saku, et al.
ESC Heart Failure|February 9, 2022
The use of angiotensin II receptor blocker is associated with greater recovery of cardiac function than angiotensin-converting enzyme inhibitor in dilated cardiomyopathyNobuyuki Enzan, Shouji Matsushima, Tomomi Ide, et al.
JACC. Asia|March 6, 2023
Beneficial Effects of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure With Preserved Ejection Fraction and DiabetesNobuyuki Enzan, Shouji Matsushima, Hidetaka Kaku, et al.
Physiological Reports|October 28, 2025
Simulated microgravity exposure markedly attenuates the baroreflex total loop gain and induces orthostatic hypotension in male ratsKazuhiro Kamada, Hiroshi Mannoji, Takeshi Tohyama, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Beta-blockers are associated with reverse remodeling in patients with dilated cardiomyopathy and mid-range ejection fractionNobuyuki Enzan, Shouji Matsushima, Tomomi Ide, et al.
International Heart Journal|July 19, 2021
The Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Is Associated with the Recovered Ejection Fraction in Patients with Dilated CardiomyopathyNobuyuki Enzan, Shouji Matsushima, Tomomi Ide, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 30, 2023
Regional Variation in the Clinical Practice and Prognosis in Patients With Heart Failure With Reduced Ejection Fraction in Japan - A Report From the Japanese Registry of Acute Decompensated Heart Failure (JROADHF)Yu Sato, Akiomi Yoshihisa, Tomomi Ide, et al.
Open Heart|December 23, 2025
Long-term prognostic impact of in-hospital serum albumin concentration changes in patients hospitalised for heart failureKeiko Fukino, Satoshi Miyata, Tomomi Ide, et al.
Circulation Reports|March 19, 2021
Clinical Characteristics and Contemporary Management of Patients With Cardiomyopathies in Japan - Report From a National Registry of Clinical Personal RecordsNobuyuki Enzan, Shouji Matsushima, Tomomi Ide, et al.
Pageof 6